Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Therapy Durations Defined by the Blood RNA-based Model for Individualizing Treatment in Multidrug-Resistant Tuberculosis

NCT04783727 is registered in ClinicalTrials.gov with Research Center Borstel as lead sponsor.

NCT NCT04783727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04783727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Therapy Durations Defined by the Blood RNA-based Model for Individualizing Treatment in Multidrug-Resistant Tuberculosis
Lead sponsor
Research Center Borstel
Phase
Not applicable
Overall status
Terminated
Start date
April 1, 2021
Completion date
November 1, 2022
Enrollment
4 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections, mycobacterial infection, tuberculosis, multidrug-resistant, tuberculosis, pulmonary